Abstract -Aims: To study pregnancy outcome in women with alcoholic liver disease (ALD). Methods: Using the Swedish nation-wide Patient and Medical Birth Registers, we investigated risk of adverse pregnancy outcome in 720 women diagnosed with ALD before and 1720 diagnosed after birth and compared them with 24 460 population-based control births. Results: Women with ALD diagnosed before or after birth were generally of higher age and body mass index, more likely to smoke cigarettes during pregnancy and to have a low socio-economic status compared with controls. Women diagnosed with ALD before birth had an increased risk of moderately and very preterm birth, adjusted odd ratio (OR) = 1.53 (95% confidence interval (CI): 1.37-1.72 and 1.15-2.06 95%), respectively. Infants of mothers with ALD before birth were more often small-for-gestational age, adjusted OR = 1.22 (95% CI: 1.05-1.43), and were at increased risk for low Apgar scores (<7) at 5 min, adjusted OR = 1.49 (95% CI: 1.15-1.92) compared with controls. Similar associations with slightly lower-risk estimates were found among women diagnosed with ALD after birth. Conclusions: ALD is associated with adverse-birth outcomes, highlighting the importance of screening women for alcohol dependence in antenatal care.
INTRODUCTION
Alcohol consumption is a major cause of chronic liver disease. Women hospitalized with alcoholic liver disease (ALD) have an increased mortality compared with women hospitalized with non-ALD (Stokkeland et al., 2006; Stokkeland and Ekbom, 2010) . Women with ALD drink less than men with ALD, but during the last decade there has been an increase in alcohol consumption among women in Sweden with an increasing frequency of hospitalization and mortality for ALD (Stokkeland et al., 2008; Ramstedt et al., 2010) .
Alcohol consumption during pregnancy has been linked to poor-birth outcomes and long-term cognitive and behavioral deficits (Hoyme et al., 2005) . Abusive and heavy drinking are associated with fetal alcohol syndrome (FAS) which includes growth restriction, central nervous system damage, neurodevelopmental delays and facial malformations (Jones and Smith, 1973) . Even in the absence of FAS heavy alcohol consumption during pregnancy is correlated with adverse outcomes including miscarriage, stillbirth, preterm delivery and small-for-gestational age (SGA) birth (Guerrini et al., 2009) . However, convincing evidence of adverse effects related to low to moderate prenatal exposure to alcohol is lacking (Henderson et al., 2007) .
Studying amount and timing of alcohol intake during pregnancy is complicated by recall bias, residual confounding of socio-economic and life-style factors such as cigarette smoking and underreporting of drinking during pregnancy. Therefore we used information on ALD as a marker of heavy alcohol use.
We investigated the risks of complication of pregnancy and childbirth in mothers hospitalized with ALD before or after delivery compared with women not hospitalized for ALD taking maternal characteristics such as cigarette smoking and socio-economic status into account.
MATERIALS AND METHODS
From the Swedish patient register (PAR), we obtained information on women with a diagnosis of ALD. The PAR started in 1964 and from 1987 the register covers all public in-patient care in Sweden. Date of first ALD diagnosis according to the international classification of diseases (ICD) codes (ICD-8, ICD-9 and ICD-10) was recorded. Data from PAR were linked with the Swedish medical birth register (MBR) for women giving birth between 1983 and 2008 using the unique personal identification number assigned to each citizen at birth or immigration (Ludvigsson et al., 2011) . We used 1983 as the first year because smoking was first included in MBR since 1983. For each delivery among women with ALD we have selected 10 control women matched for year of birth and infant sex.
Data from the MBR include information on~98% of all births in Sweden with information regarding the mother as well as the pregnancy-, delivery-and neonatal period (Cnattingius et al., 1990) . Data are prospectively collected starting at the woman's first antenatal visit, which usually occurs before the 15th week of gestation.
Maternal age at birth was classified into three groups: <25 years, 25-34 years and ≥35 years. From height and weight measurements at the first visit to antenatal care we calculated body-mass index (BMI) as kilograms divided by the square of height in meters (kg/m 2 ). Women were categorized as lean or normal weight (BMI ≤ 25 kg/m 2 ), overweight kg/m 2 ) and obese (BMI ≥ 30.0 kg/m 2 ). Parity was classified into nulliparous or parous women. Women were classified according to whether they were living with their partner or not. Cigarette smoking at the first attendance to antenatal care was recorded as no daily smoking or daily smoking. Through linkage with the Statistics Sweden, information on the number of years of formal education completed two years before the birth of the child was obtained Alcohol and Alcoholism Vol. 48, No. 2, pp. 166-171, 2013 doi: 10.1093/alcalc/ags122 Advance Access Publication 16 November 2012 and categorized as: <9 years, 9-12 years or >12 years and women were classified according to high-or low-income and whether they had received social support or not. The country of birth was categorized into: Sweden, other Nordic, non-Nordic European and non-European.
Preeclampsia was defined according to ICD-9 codes such as 642E, 642F, 642G and 642H or ICD-10 codes such as O14 and O15, and gestational diabetes were defined according to ICD-9 codes such as 648W or ICD-10 code O244. Information about stillbirth at 28 weeks of gestation or later, birth weight and infant sex was obtained from the standardized pediatric record, routinely filled out immediately after delivery. A low-birth weight was defined as <2500 g. SGA birth was defined as birth weight <2 standard deviations (SDs) below the mean for gestational age according to the Swedish reference curve of estimated foetal growth (Marsal et al., 1996) . Gestational age at birth was categorized into: very preterm (<32 weeks), moderately preterm (32-36 weeks) and term (37-44 weeks). Information on congenital malformation was obtained from diagnosis when the infant was discharged from the delivery hospital (ICD-9: 740A-759X, ICD-10: Q00-Q99). Information on infant mortality was obtained from the causes of death register and categorized into early neonatal (0-6 days) and neonatal (0-27 days) death.
The risk of adverse pregnancy outcomes in relation to ALD was estimated by crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) by using conditional logistic-regression analysis. Women with a previous diagnosis of ALD before or after delivery were compared with women with no ALD diagnosis taking possible confounders such as maternal age, BMI, parity, years of formal education, cigarette smoking, calendar year of delivery, cohabitation status, income, social support and country of birth into account. Data were analyzed using the SAS software (SAS Institute Inc., Cary, NC, USA). The study confirms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in the approval by the local Ethical Committee in Stockholm, Sweden.
RESULTS

Descriptive data
We included 720 first-time singleton mothers hospitalized with ALD before, and 1726 mothers hospitalized with ALD after the birth of the child with 6907 and 17 553 populationbased controls, respectively. The mean number of months from the diagnosis of ALD to the birth of the child was 86, and the median was 71 among mothers hospitalized with ALD before the birth. The mean number of months from the birth of the child to the mother's first hospitalization for ALD was 135, and the median was 133.
In Table 1 we present birth characteristics of the women hospitalized with ALD before the birth of the child. They were generally older than their controls, 30.29% were 35 years or older compared with 14.48% in the control group. Daily cigarette smoking at admission to antenatal care was more common among mothers with ALD (79.29%) compared with controls (20.24%). Fewer of the mothers with liver disease were living with the baby's father (72.29%) compared with controls (5.49%). Nearly half of all mothers with ALD had received social support, (48.06%), and few had >12 years of education (5.27%) compared with controls (28.27%).
Similar descriptive data were found for the women who were hospitalized with ALD after the birth of the child (Supplementary data, Table S1 ).
Birth outcomes
Women with ALD before birth had increased rates of adverse-birth outcomes. The prevalence of moderately preterm birth was 12.40% and the prevalence of very preterm birth was 1.39%, compared with 5.32 and 0.84%, respectively among controls (Table 2) . We found an increased proportion of low-birth weight (<2500 g) and SGA infants among women with a previous diagnosis of ALD compared with controls. The prevalence of low Apgar scores at 5 min was 2.23% in women with hospitalized with ALD compared with 1.08% among controls. Women with ALD were more likely to have a cesarean section, (23.51%), than controls (14.28%). There were only 2 (0.28%) stillbirths among women hospitalized with ALD before the birth and 9 (0.52%) among women who were hospitalized after the birth, which was higher than in the controls (0.14 and 0.27%, respectively). For women who were hospitalized with ALD after the birth of the child, the rate of adverse-birth outcomes were similar, but lower in magnitude compared with women with ALD before birth (Table 3) . Crude and adjusted relative risks for the adverse-birth outcomes are presented in Tables 2 and 3 . When we adjusted for maternal age, parity, smoking and cohabiting status (model 1) women with ALD before birth were at increased risks for gestational diabetes (adjusted OR 2.02, 95% CI: 1.61-2.57), cesarean section (adjusted OR 1.29, 95% CI:1.20-1.38), low 5-min Apgar score (adjusted OR 1.61, 95% CI: 1.32-1.95), very preterm birth (adjusted OR 1.58, 95% CI: 1.27-1.98), moderately preterm birth (adjusted OR 1.53, 95% CI:1.41-1.67), low-birth weight (adjusted OR 1.52, 95% CI:1.38-1.68) and small-for-gestational-age birth (1.33, 95% CI: 1.19-1.42) compared with controls. There was no association between ALD before birth and risk of preeclampsia (adjusted OR 1.10, 95% CI: 0.92-1.31) or congenital malformations (adjusted OR 1.00, 95% CI: 0.89-1.14). Relative risks associated with ALD before birth generally decreased when additional adjustments were made for maternal country of birth, educational level, income and social support (model 2). Similar relative risks but generally of lower magnitude were found among women with ALD hospitalization after birth (Table 3) .
DISCUSSION
In this large nation-wide study we found that women with ALD were at an increased risk of adverse pregnancy outcome including preterm and SGA birth. Risks were highest among women hospitalized with ALD before delivery. The increased risk of preterm birth could be attributed to alcohol intake during pregnancy but also the chronic liver disease per se. Chronic liver disease is associated with increased levels of inflammatory cytokines, which may increase the risk of preterm birth (Goldberg et al., 2008) . A Danish study found that alcohol consumption below four drinks per week did not increase the risk of preterm birth, women in that study who consumed 2-3.5 drinks per week had a 20% reduction in risk (Albertsen et al., 2004) . Several recent studies found alcohol to be a risk factor for preterm birth, and their results are in line with our findings (Odendaal et al., 2009; O'Leary et al., 2009; Aliyu et al., 2010; Mullally et al., 2011) . Smoking was adjusted for in multivariate analyses, and the risk estimates for preterm birth and low-birth weight among women with ALD are well in line with earlier studies in women with high alcohol consumption during pregnancy (Odendaal et al., 2009) . We suggest that the increased risk of preterm deliveries is caused both by the effects of the alcohol use during pregnancy and the chronic liver disease.
There was a nearly 40% increase in risk of experiencing a stillbirth for women with ALD diagnosed before pregnancy. However, the numbers of stillbirth were few and did not reach statistical significance in the adjusted models and it should consequently be interpreted with caution. Our results suggest that the ALD may be associated with stillbirth.
Among women with ALD the proportion of infants with low Apgar scores was increased. A case-cohort study with 2002 pregnant women failed to show any significant relationship between low and moderate maternal alcohol intake and newborn clinical status, including Apgar scores (Walpole et al., 1990) . According to the authors the advice that any alcohol taken during pregnancy is potentially harmful was considered inaccurate and therefore probably counterproductive. Moderate alcohol consumption has in a later case-cohort study shown to be associated with an increased risk of low Apgar scores and several other indicators of neonatal morbidity and the latter findings are in line with our results. No increase was found for low Apgar scores in a case-control study of mothers with hepatitis The children are presented as numbers (n) and frequency of the total number of children (%). And the risks are presented as ORs and adjusted ORs. C-infection, but in a cohort of carriers of the hepatitis B surface gen there were low Apgar scores in the 1st and 5th min, and several detrimental birth outcomes (Meyer-Leu et al., 2011) . There were more women with ALD who had a cesarean section in our study. We think that our findings strongly support a negative effect of alcohol on Apgar scores; we cannot rule out that the liver disease contributes to these findings. In our study the cohort of mothers with ALD to have a high frequency of smokers, low-education level and high frequency of social support. Although we adjusted for these variables in the multivariate analysis, residual confounding cannot be ruled out. Not only could these markers of a socially stressful life situation serve as confounders, but they may also be markers of other specific risks such as family violence and drug use that may increase stress and thereby risk of negative birth outcomes.
Obesity is in itself a risk factor for adverse pregnancy outcomes (Cnattingius et al., 1998) . Obesity also results in fat deposits in the liver and is an independent risk factor for liver cirrhosis. Together with an increased alcohol consumption obesity is shown to substantially increase the rate of liver cirrhosis (Liu et al., 2010) . On the contrary, there is one study of mothers who gave birth to children with FAS who showed that the average weight of the mothers were significantly lower compared with controls . We did not find any significant differences in BMI between mothers with ALD compared with controls (P = 0.24 and 0.11 for ALD). There were only 41 obese mothers and we found them too few for further analyses. We suggest that our study does not have the power to investigate the association between alcohol liver disease during pregnancy and adverse pregnancy outcomes stratified by maternal BMIs.
The present population-based study includes >2400 births among women with ALD in Sweden between 1983 and 2008. The ALD diagnosis was based on hospitalizations which precludes the role of recall bias. Controls were matched for year of birth and infant sex. To perform this study as a clinical cohort study is probably impossible because of ethical considerations and problems with consent from both mothers and children, especially since we have studied mothers with sensitive diagnoses, i.e. alcohol dependence and ALD and diagnoses related to childbirth. This study has several limitations. First, the amount of alcohol consumed by the mother before, during and after the pregnancy is not known, as this information is not recorded in the MBR. We know only the influence of previous alcohol exposure-it has led to hospitalization for ALD. Being hospitalized with ALD is surely a marker of serious alcohol-related problems. We do not know when the exposure to alcohol took place and consequently we don't know whether the alcohol exposure was stopped prior to or during pregnancy. In addition we do not have information on medication and other illicit drugs that the mother may have used during pregnancy. The present study does not include women with ALD who were not hospitalized for the disease and the results may not be generalizable to all women with ALD. Most of the patients with severe liver disease will be hospitalized sooner or later with decompensation symptoms, and we have included women who were hospitalized with liver disease after the birth of the child to cover more of the women. The Swedish PAR has almost 100% coverage, but the PAR did not reach nation-wide coverage until 1987, from 1977 it covered >75% of all hospital discharges, so we think that our data quality is good. The incomplete coverage of the register and the inclusion of only the hospitalized women with ALD could lead to an underestimation of risks associated with ALD. In addition the women with ALD who are identified would in most cases get special attention at the antenatal follow-ups and therefore the risks for unidentified women with ALD may be higher that we have calculated.
We also present data from children whose mothers later were hospitalized for ALD in our study. Some of these women will probably not have an ALD at the time of delivery, but as liver disease takes many years of alcohol exposure to develop there will probably be many women with liver disease at the birth of the child. There will also be many who have high alcohol consumption, so we find it relevant to present the data to show the effects of such exposure.
In conclusion ALD was associated with adverse pregnancy outcomes especially among women diagnosed before delivery. Screening for alcohol use in antenatal care could identify high-risk women and thereby prevent pregnancy and birth complications.
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